GTP cyclohydrolase I and tyrosine hydroxylase gene mutations in familial and sporadic dopa-responsive dystonia patients.
Dopa-responsive dystonia (DRD) is a rare inherited dystonia that responds very well to levodopa treatment. Genetic mutations of GTP cyclohydrolase I (GCH1) or tyrosine hydroxylase (TH) are disease-causing mutations in DRD. To evaluate the genotype-phenotype correlations and diagnostic values of GCH1...
Main Authors: | Chunyou Cai, Wentao Shi, Zheng Zeng, Meiyun Zhang, Chao Ling, Lei Chen, Chunquan Cai, Benshu Zhang, Wei-Dong Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3675154?pdf=render |
Similar Items
-
Serotonergic system in vivo with [11C]DASB PET scans in GTP-cyclohydrolase deficient dopa-responsive dystonia patients
by: Elze R. Timmers, et al.
Published: (2022-04-01) -
Brain Transplantation of Neural Stem Cells Cotransduced with Tyrosine Hydroxylase and GTP Cyclohydrolase 1 in Parkinsonian Rats
by: M. Y. Ryu, et al.
Published: (2005-04-01) -
Parkinson's disease in GTP cyclohydrolase 1 mutation carriers.
by: Ryan, B, et al.
Published: (2014) -
Degradation of Tyrosine Hydroxylase by the Ubiquitin-Proteasome System in the Pathogenesis of Parkinson’s Disease and Dopa-Responsive Dystonia
by: Ichiro Kawahata, et al.
Published: (2020-05-01) -
Personalized Medicine to Improve Treatment of Dopa-Responsive Dystonia—A Focus on Tyrosine Hydroxylase Deficiency
by: Gyrid Nygaard, et al.
Published: (2021-11-01)